Chronic inflammation of tuberculosis

Anas Khalil, Kuan Jen Bai, Shawn Hsiang Yin Chen

研究成果: 書貢獻/報告類型章節

摘要

Managing Tuberculosis (TB) infection remains a challenge and there is a need for modern science to infuse new principles. Better use of existing medications, at the stage without effective vaccines and newly developed medications, is a field in urgent need of research effort. This classical infectious disease, in year 2011 alone, actively infected 8.7 million people and 1.4 million people died. TB and human immunodeficiency virus (HIV) HIV co-infection, multidrug-resistant (MDR) as well as extensively drug-resistant (XDR) TB, and clinically significant adverse drug reactions resulting from long-term medication treatment, altogether contributes to complex treatment problems and TB control challenges worldwide. Pharmacogenetics, together with pharmacoepidemiology studies, would help establish better clinical strategies for evaluating, treating, and monitoring tuberculosis patients. Factors affecting the treatment outcome of TB would be an important domain for clinical research. These include reducing patient default from anti-TB treatment, enhancing the adherence of medication administration, improving the cure rate, avoiding TB relapse, and preventing activation of TB infection. Research efforts thus are warranted to investigate the potential risk factors for TB infection from many aspects: comorbidities, social-economic status, health-related behaviors, occupations, use of certain immunosuppressing medications and genetic involvement. For example, monitoring some genetic variations at some loci of the essential liver enzymes, for instance: monitoring the N-acetlytransferase 2 (NAT2), Cytochrome P450 oxidase (CYP2E1), glutathione S-transferases family (GSTs) that metabolizes and detoxifies anti- TB drugs would give good information about these drug responses and their toxicity. Further, this would help to design personalized medicine for TB in the future.
原文英語
主出版物標題Chronic Inflammation: Causes, Treatment Options and Role in Disease
發行者Nova Science Publishers, Inc.
頁面171-194
頁數24
ISBN(列印)9781628080940
出版狀態已發佈 - 2013

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Chronic inflammation of tuberculosis」主題。共同形成了獨特的指紋。

  • 引用此

    Khalil, A., Bai, K. J., & Chen, S. H. Y. (2013). Chronic inflammation of tuberculosis. 於 Chronic Inflammation: Causes, Treatment Options and Role in Disease (頁 171-194). Nova Science Publishers, Inc..